# ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer

> **NCT06579417** · — · RECRUITING · sponsor: **University of California, San Diego** · enrollment: 500 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** RSI MRI

## Key facts

- **NCT ID:** NCT06579417
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-15
- **Primary completion:** 2026-07
- **Final completion:** 2029-07
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-11-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06579417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06579417, "ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06579417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*